Birgitte Preiss

888 total citations
25 papers, 554 citations indexed

About

Birgitte Preiss is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Birgitte Preiss has authored 25 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Birgitte Preiss's work include Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Acute Lymphoblastic Leukemia research (6 papers). Birgitte Preiss is often cited by papers focused on Acute Myeloid Leukemia Research (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Acute Lymphoblastic Leukemia research (6 papers). Birgitte Preiss collaborates with scholars based in Denmark, United States and Germany. Birgitte Preiss's co-authors include Lone Smidstrup Friis, Eigil Kjeldsen, Mette Klarskov Andersen, Claus Werenberg Marcher, Jan Maxwell Nørgaard, Marianne Tang Severinsen, Bruno C. Medeiros, Lene Sofie Granfeldt Østgård, Mette Nørgaard and Henrik Sengeløv and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Birgitte Preiss

24 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgitte Preiss Denmark 12 461 207 156 143 142 25 554
Bianca F. Goemans Netherlands 10 419 0.9× 200 1.0× 115 0.7× 85 0.6× 147 1.0× 34 563
Chun Yew Fong Australia 12 425 0.9× 266 1.3× 114 0.7× 92 0.6× 93 0.7× 50 600
Montserrat Torrebadell Spain 10 354 0.8× 224 1.1× 189 1.2× 144 1.0× 114 0.8× 21 571
Yue‐Yun Lai China 14 542 1.2× 196 0.9× 256 1.6× 119 0.8× 159 1.1× 79 693
Prapti A. Patel United States 13 323 0.7× 240 1.2× 91 0.6× 156 1.1× 66 0.5× 60 532
Teresa Davies United Kingdom 7 482 1.0× 210 1.0× 340 2.2× 90 0.6× 160 1.1× 9 719
Costanza Bosi Italy 13 385 0.8× 281 1.4× 210 1.3× 52 0.4× 76 0.5× 25 630
Iman Abou Dalle Lebanon 12 261 0.6× 140 0.7× 60 0.4× 107 0.7× 122 0.9× 46 430
Jerry Radich United States 11 518 1.1× 89 0.4× 248 1.6× 76 0.5× 168 1.2× 29 602
Karin Nebral Austria 12 294 0.6× 178 0.9× 72 0.5× 83 0.6× 284 2.0× 31 513

Countries citing papers authored by Birgitte Preiss

Since Specialization
Citations

This map shows the geographic impact of Birgitte Preiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgitte Preiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgitte Preiss more than expected).

Fields of papers citing papers by Birgitte Preiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgitte Preiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgitte Preiss. The network helps show where Birgitte Preiss may publish in the future.

Co-authorship network of co-authors of Birgitte Preiss

This figure shows the co-authorship network connecting the top 25 collaborators of Birgitte Preiss. A scholar is included among the top collaborators of Birgitte Preiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgitte Preiss. Birgitte Preiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hansen, Marcus Høy, Oriane Cédile, Mads Thomassen, et al.. (2023). Toward Cytogenomics. Journal of Molecular Diagnostics. 25(11). 796–805. 3 indexed citations
2.
Klausen, Tobias Wirenfeldt, Birgitte Preiss, Carsten Helleberg, et al.. (2021). The real-world outcomes of multiple myeloma patients treated with daratumumab. PLoS ONE. 16(10). e0258487–e0258487. 14 indexed citations
3.
Gregersen, Henrik, Tobias Wirenfeldt Klausen, Birgitte Preiss, et al.. (2021). Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients. Hematological Oncology. 39(4). 521–528. 2 indexed citations
4.
Thorsen, Jonathan, Birgitte Preiss, Carsten Helleberg, et al.. (2021). The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy. Blood. 138(Supplement 1). 3779–3779. 4 indexed citations
5.
Assing, Kristian, Christian Nielsen, Marianne Antonius Jakobsen, et al.. (2020). Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report. BMC Infectious Diseases. 20(1). 878–878. 1 indexed citations
6.
Nørgaard, Jan Maxwell, Lone S. Friis, Marianne Tang Severinsen, et al.. (2019). Addressing the room for improvement in management of acute promyelocytic leukemia. European Journal Of Haematology. 102(6). 479–485. 4 indexed citations
7.
Holdgaard, Paw Christian, et al.. (2019). Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm. A single-case report. Haematologica. 104(9). e432–e433. 11 indexed citations
8.
Sørrig, Rasmus, Tobias Wirenfeldt Klausen, Birgitte Preiss, et al.. (2018). Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014. Leukemia. 32(9). 2054–2057. 7 indexed citations
9.
Sørrig, Rasmus, Tobias Wirenfeldt Klausen, Morten Salomo, et al.. (2017). Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population. PLoS ONE. 12(12). e0188988–e0188988. 37 indexed citations
10.
Frederiksen, Henrik, et al.. (2017). Refractory primary immune thrombocytopenia with subsequent del(5q) MDS: complete remission of both after lenalidomide. BMJ Case Reports. 2017. bcr2016215888–bcr2016215888. 2 indexed citations
11.
Nahi, Hareth, Thea Kristin Våtsveen, Johan Lund, et al.. (2015). Proteasome inhibitors and IMiDs can overcome some high‐risk cytogenetics in multiple myeloma but not gain 1q21. European Journal Of Haematology. 96(1). 46–54. 31 indexed citations
12.
Andersen, Niels Frost, Ida Bruun Kristensen, Birgitte Preiss, Jacob Haaber Christensen, & Niels Abildgaard. (2014). Upregulation of Syndecan‐1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis. European Journal Of Haematology. 95(3). 211–217. 12 indexed citations
13.
14.
Nørgaard, Jan Maxwell, Lene Sofie Granfeldt Østgård, Eigil Kjeldsen, et al.. (2012). High Early Death Rate with Excellent Survival Beyond Day 30 in Acute Promyelocytic Leukemia Confirmed in Unselected Patients: Results of a Population-Based Registry Study. Blood. 120(21). 3542–3542.
15.
Kristensen, Thomas Kielsgaard, Michael Møller, Lone Smidstrup Friis, Olav J. Bergmann, & Birgitte Preiss. (2011). NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression*. European Journal Of Haematology. 87(5). 400–408. 34 indexed citations
16.
Kristensen, Thomas Kielsgaard, Birgitte Preiss, Sigurd Broesby‐Olsen, et al.. (2011). Systemic mastocytosis is uncommon inKITD816V mutation positive core-binding factor acute myeloid leukemia. Leukemia & lymphoma. 53(7). 1338–1344. 8 indexed citations
17.
Preiss, Birgitte, et al.. (2010). Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML. Cancer Genetics and Cytogenetics. 202(2). 108–122. 20 indexed citations
18.
19.
Preiss, Birgitte, Gitte Kerndrup, Kai Gjerløff Schmidt, et al.. (2003). Cytogenetic findings in adult de novo acute myeloid leukaemia. A population‐based study of 303/337 patients. British Journal of Haematology. 123(2). 219–234. 27 indexed citations
20.
Preiss, Birgitte, et al.. (1999). A Case of Childhood Acute Myeloid Leukemia Associated with Inversion (7)(p21q31). Cancer Genetics and Cytogenetics. 108(2). 144–148. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bianca F. Goemans Breakdown of academic impact, for papers by Chun Yew Fong Breakdown of academic impact, for papers by Montserrat Torrebadell Breakdown of academic impact, for papers by Yue‐Yun Lai Breakdown of academic impact, for papers by Prapti A. Patel Breakdown of academic impact, for papers by Teresa Davies Breakdown of academic impact, for papers by Costanza Bosi Breakdown of academic impact, for papers by Iman Abou Dalle Breakdown of academic impact, for papers by Jerry Radich Breakdown of academic impact, for papers by Karin Nebral
Rankless by CCL
2026